Physician profile
John S Schor
NPI 1568459717
$4,962.22
in general payments reported to CMS, 2019-2025
30 companies · $416 in 2025
The $416 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $503 · 2020: $1,372 · 2021: $771 · 2022: $565 · 2023: $482 · 2024: $854 · 2025: $416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,751.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,751.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $1,035.24 | 2020-2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Cook Medical LLC | $976.32 | 2019-2025 | Zenith, Zenith Spiral-Z, Zenith Alpha |
| Boston Scientific Corporation | $581.20 | 2019-2025 | Ekosonic, Latitude Communicator Power Supply, Cds - Mct/Cem Monitoring |
| Inari Medical, INC. | $541.22 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Endologix LLC | $403.90 | 2020-2021 | |
| Medtronic, INC. | $349.91 | 2021-2023 | Endurant Iis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $191.02 | 2020-2023 | Lifevest |
| Medtronic Vascular, INC. | $107.52 | 2019 | |
| Janssen Pharmaceuticals, INC | $80.08 | 2019-2022 | |
| Philips North America LLC | $70.08 | 2023 | |
| Abbott Laboratories | $67.82 | 2019-2021 | |
| Amgen INC. | $52.50 | 2020-2024 | Repatha |
| Sanofi-Aventis U.S. LLC | $51.29 | 2019-2024 | |
| Abiomed | $44.99 | 2024-2025 | Impella |
| Regeneron Healthcare Solutions, INC. | $40.46 | 2021-2025 | Evkeeza |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $38.33 | 2025 | Flowtriever |
| Esperion Therapeutics, INC. | $37.99 | 2021-2024 | Nexletol |
| Novo Nordisk INC | $37.01 | 2021 | |
| Amarin Pharma, INC. | $29.39 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $26.88 | 2019-2021 | |
| Bard Peripheral Vascular, INC. | $25.07 | 2023 | Venovo |
| Chiesi USA, INC. | $24.30 | 2025 | Juxtapid |
| Grifols USA, LLC | $22.50 | 2019 | |
| Amryt Pharma Holdings LTD | $22.00 | 2022 | |
| Atricure, INC. | $21.56 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $20.83 | 2024 | Arcalyst |
| Kowa Pharmaceuticals America, INC. | $19.23 | 2023 | Livalo |
| Olympus America INC. | $19.18 | 2024 | Single Use Repositionable Clip |
| Merck Sharp & Dohme LLC | $12.41 | 2021 | |
| Tactile Systems Technology INC | $11.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Schor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.